As Action on Senate Finance Committee Drug Pricing Bill Set to Resume, National LTC Pharmacy Advocacy Group Praises Cap on Patient Costs
SCPC Will Seek Cap “As Low as Possible” in Final Bill, Offer Two Policy Refinements
Washington, DC – Commenting on several elements of the Senate Finance Committee’s pending drug pricing bill, the Senior Care Pharmacy Coalition (SCPC) praised the broad contours of the sweeping legislation and offered strong support for the proposed cap on Medicare Part D beneficiaries’ out-of-pocket costs.
“Capping out-of-pocket costs — and ultimately passing a final bill with caps as low as possible — would make drugs more affordable for elderly patients and improve their ability to pay for drugs, sustain their prescribed regimen, and improve their overall health,” stated Alan G. Rosenbloom, President and CEO of SCPC.
He also pointed out the bill includes disclosure provisions for Pharmacy Benefit Managers (PBM) to the Centers for Medicare and Medicaid Services (CMS) — and for CMS to the public — which would benefit consumers.
As the legislation moves forward, Rosenbloom said SCPC would offer two policy refinements:
- More marketplace competition must be a companion to additional PBM transparency, as transparency alone will not address the increasingly oligopolistic nature of the pharmaceutical marketplace;
- Provisions that require reporting of information specific to retail pharmacies should logically be expanded to require reporting of data specific to LTC pharmacies.
“We look forward to working in the coming weeks with Chairman Grassley, Ranking Member Wyden and members of the Committee to advance a positive bill and improve it for the benefit of the nation’s independent long-term care pharmacies and the elderly, vulnerable patients they serve,” Rosenbloom concluded.
###
Recent Posts
-
Rep. Beth Van Duyne: Congress can save seniors’ access to medications before it’s too late
Seniors in nursing homes across the country depend on round-the-clock care and medications, perhaps more than any other American patient population. In turn, the nursing homes and assisted living facilities that care for them depend on a small number of specialized long-term care (LTC) pharmacies to ensure their patients have access to the prescription meds they need.
-
Bill Aims to Offset Reimbursement Losses for Long-Term Care Pharmacies Catering to Nursing Homes
Starting in January, falling prices for costly drugs may strain long-term care pharmacies, but proposed legislation backed by advocacy groups aims to subsidize some of this loss. And nursing home advocacy groups are among those urging Congress to pass the Preserving Patient Access to Long-Term Care Pharmacies Act.
-
Drug pricing policy could jeopardize long-term care pharmacies, leaders contend
Senior living and care leaders have joined a coalition calling attention to a policy fix they say would address unintended consequences of Medicare Part D price negotiations that could shutter long-term care pharmacies.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.